AngioDynamics Stock Is Falling Thursday: What's Going On?
ANGO stock drops 21% as AngioDynamics reports Q1 results, names Eric Honroth as new CEO, and reaffirms FY27 guidance.
Stocks · News reference
Earnings Scheduled For October 8, 2026
Companies Reporting Before The Bell • Tilray Brands (NASDAQ:TLRY) is likely to report quarterly loss at $0.15 per share on revenue of $266.42 million. • Helen Of Troy (NASDAQ:HELE) is projected to report quarterly
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Crude Oil Gains 5%; PepsiCo Posts Upbeat Q3 Earnings
U.S. stocks fell Thursday as Nasdaq slid 150+ points; energy rallied, healthcare dropped. PepsiCo beat estimates but cut FY26 outlook; oil jumped 5%.
AngioDynamics shares are trading lower after the company reported Q1 financial results. The company reported a year-over-year decrease in its AngioVac sales.
AngioDynamics Q1 2027 Earnings Call: Complete Transcript
AngioDynamics (NASDAQ:ANGO) reported first-quarter financial results on Thursday. The transcript from the company's first-quarter earnings call has been provided below. This transcript is brought to you by Benzinga
Byrna Technologies shares are trading higher after the company reported Q3 results. The company reportedly cut production costs.
Byrna Technologies Q3 2026 Earnings Call Transcript
On Thursday, Byrna Technologies (NASDAQ:BYRN) discussed third-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you by Benzinga APIs. For real-time